Peter Meldrum Insider Profile
4 Followers
Peter Meldrum, President & C.E.O., Director at Myriad Genetics, holds 2.25K shares in Endocyte (Ticker: ECYT), holds 10.42K shares in Myriad Genetics (Ticker: MYGN).
Peter Meldrum's Trading History
| ECYTEndocyte | May 05, 2017 | ― | Uninformative Buy | ― | $53.98K | |
| MYGNMyriad Genetics | May 08, 2015 | President & C.E.O., Director | Informative Buy | 99.99K | $59.10K |
You May Also Like
Peter Meldrum insider profile FAQ
What is the percentage of profitable transactions made by Peter Meldrum?
The percentage of profitable transactions made by Peter Meldrum is 67%.
What is the average return per transaction made by Peter Meldrum?
The average return per transaction made by Peter Meldrum is 6.10%.
What stocks does Peter Meldrum hold?
Peter Meldrum holds: MYGN, ECYT stocks.
What was Peter Meldrum's most profitable transaction?
Peter Meldrum’s most profitable transaction was an Informative Buy of MYGN stock on November 6, 2014. The return on the trade was 26.70%.
What is Peter Meldrum's role in Myriad Genetics?
Peter Meldrum's role in Myriad Genetics is President & C.E.O., Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
